Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions

Cancer(2025)10.1002/cncr.35784Source: DataRank Database

Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions is a research paper published in Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 10.86)OA: bronzeTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Matteo Repetto ORCID,Soo‐Ryum Yang ORCID,Antoine Desîlets ORCID

Live enrichment

PubMed:40171848 PMC:PMC12551656 OpenAlex:https://openalex.org/W4409118862

NIH HHS

Grant: P30CA008748

NCI NIH HHS

Grant: R01 CA251591

NCI NIH HHS

Grant: R01 CA273224

FWCI

10.86

Citation Percentile

1.0%

Citation Trend

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.35784?download=true

publisherhttps://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.35784?download=true

publisherhttps://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.35784

journalhttps://doi.org/10.1002/cncr.35784

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40171848

Fields of Study

Lung Cancer Treatments and MutationsCancer therapeutics and mechanismsLung Cancer Research Studies

MeSH Terms

CrizotinibAminopyridinesBenzamidesCarcinoma, Non-Small-Cell LungHumansIndazolesLactamsLung NeoplasmsMutationProtein-Tyrosine KinasesProto-Oncogene ProteinsPyrazolesPyrimidinesGene RearrangementDrug Resistance, NeoplasmProtein Kinase InhibitorsMolecular Targeted Therapy

Keywords

ROS1CrizotinibMedicineLung cancerTargeted therapyCancer researchCancerCabozantinibAdenocarcinomaOncologyInternal medicineTyrosine kinase inhibitorNon–small Cell Lung CancerRos1 Fusion

Sustainable Development Goals

SDG 0: Good health and well-being